Stryker Corporation Income Statement
SYK / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Stryker Corporation reported $5.9B in revenue and $654M in net income for FY2025. Revenue has declined at a 1.0% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.9B | $22.6B | $17.1B | $14.4B | $17.1B | $13.6B | $12.4B | $11.3B | $9.9B | $9.7B | $9.9B | $9.7B | $9.0B | $7.3B | $6.7B |
| Cost of Revenue | $9.1B | $8.2B | $6.1B | $5.3B | $6.1B | $4.7B | $4.3B | $3.8B | $3.3B | $3.3B | $3.3B | $3.3B | $3.0B | $2.3B | $2.2B |
| Gross Profit | $3.7B | $14.4B | $11.0B | $9.1B | $11.0B | $8.9B | $8.2B | $7.5B | $6.6B | $6.4B | $6.6B | $6.4B | $6.0B | $5.0B | $4.5B |
| SG&A Expense | $8.7B | $7.7B | $6.4B | $5.4B | $6.4B | $5.1B | $4.6B | $4.1B | $3.6B | $3.5B | $3.6B | $3.5B | $3.5B | $2.7B | $2.5B |
| R&D Expense | $1.6B | $1.5B | $1.2B | $984.0M | $1.2B | $862.0M | $787.0M | $715.0M | $625.0M | $614.0M | $625.0M | $614.0M | $536.0M | $394.0M | $336.0M |
| Operating Income | $4.9B | $3.7B | $2.6B | $2.2B | $2.6B | $2.5B | $2.3B | $2.2B | $1.9B | $1.2B | $1.9B | $1.2B | $1.3B | $1.8B | $1.6B |
| Interest Expense | $582.0M | $396.0M | $337.0M | $315.0M | $337.0M | $264.0M | $247.0M | $228.0M | $108.0M | $113.0M | $108.0M | $113.0M | $83.0M | $53.0M | $14.0M |
| Income Tax | $1.3B | $499.0M | $287.0M | $355.0M | $287.0M | -$1.2B | $1.0B | $274.0M | $296.0M | $645.0M | $296.0M | $645.0M | $206.0M | $456.0M | $517.0M |
| Net Income | $654.0M | $3.0B | $2.0B | $1.6B | $2.0B | $3.6B | $1.0B | $1.6B | $1.4B | $515.0M | $1.4B | $515.0M | $1.0B | $1.3B | $1.1B |
| EPS (Basic) | $8.34 | $6.23 | $5.29 | $4.26 | $5.57 | $9.50 | $2.73 | $4.40 | $3.82 | $1.36 | $2.66 | $3.41 | $3.48 | $3.21 | $2.79 |
| EPS (Diluted) | $8.25 | $6.17 | $5.21 | $4.20 | $5.48 | $9.34 | $2.68 | $4.35 | $3.78 | $1.34 | $2.63 | $3.39 | $3.45 | $3.19 | $2.77 |
| Shares Outstanding | 383.7M | 382.2M | 382.3M | 380.3M | 379.9M | 380.3M | 380.1M | 378.5M | 378.6M | 373.0M | 378.0M | 378 | 380 | 381 | 391 |
| Gross Margin | 63.8% | 63.9% | 64.1% | 63.1% | 64.1% | 65.7% | 65.7% | 66.3% | 66.4% | 65.7% | 66.4% | 65.7% | 66.7% | 68.8% | 67.5% |
| Operating Margin | 83.3% | 16.3% | 15.1% | 15.5% | 15.1% | 18.6% | 18.5% | 19.2% | 18.7% | 12.9% | 18.7% | 12.9% | 13.9% | 23.9% | 23.7% |
| Profit Margin | 11.2% | 13.3% | 11.7% | 11.1% | 11.7% | 26.1% | 8.2% | 14.5% | 14.5% | 5.3% | 14.5% | 5.3% | 11.2% | 17.4% | 16.5% |